McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its opioid painkiller OxyContin, a court filing said Friday. A former top partner at McKinsey, Martin Elling, also agreed to plead guilty to obstruction of justice next month in the probe by the U.S. Department of Justice, according to a filing in U.S. District Court in Abingdon, Virginia. The criminal charging document that McKinsey agreed to have filed by prosecutors alleges the consulting giant “knowingly and intentionally” conspired with Purdue Pharma “and others to aid and abet the misbranding of prescription drugs.” The document also said McKinsey is accused, through the acts of its then-partner Elling, of “knowingly destroying and concealing records and documents with the intent” to impede the investigation by the Department of Justice. McKinsey, which previously agreed to pay almost…
Startup basketball league Unrivaled announced on Monday it’s closed a Series A funding round, raising an additional $28 million before…
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe…
Walmart has started giving store-level associates body cameras to wear as part of a pilot program at some of its…
CrowdStrike moved Monday evening to dismiss Delta Air Lines’ lawsuit around the July cybersecurity outage that led to canceled flights and stranded…
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe…
President-elect Donald Trump and the head of Japanese tech conglomerate SoftBank, Masayoshi Son, will announce a $100 billion investment…
A rocky year for restaurants separated the industry’s biggest chains into winners and losers, as eateries competed for a…